术后肌松残余作用及应对措施研究
摘要
关键词
参考
Yu B , Ouyang B , Ge S ,et al. Incidence of postoperative residual neuromuscular blockade after general anesthesia: a prospective, multicenter, anesthetist-blind, observational study[J]. Curr Med Res Opin, 2016,32(1):1-9.
许燕,舒仕瑜.婴幼儿患者合理应用肌松药的研究进展[J].国际麻醉学与复苏杂志,2020,41(04):365-369.
Ezri T, Szmuk P, Warters RD, Gebhard RE, Pivalizza EG, Katz J. Changes in onset time of rocuronium in patients pretreated with ephedrine and esmolol--the role of cardiac output. Acta Anaesthesiol Scand. 2003 Oct;47(9):1067-72. doi: 10.1034/j.1399-6576.2003.00218.x. PMID: 12969097.
Ishigaki S, Ogura T, Kanaya A, Miyake Y, Masui K, Kazama T. Influence of preoperative oral rehydration on arterial plasma rocuronium concentrations and neuromuscular blocking effects: A randomised controlled trial. Eur J Anaesthesiol. 2017 Jan;34(1):16-21. doi: 10.1097/EJA.0000000000000526. PMID: 27606613.
王士朝.肥胖与正常女性患者罗库溴铵药效学差异研究[D].河北医科大学,2016.
夏一梦,范秋维,徐悦,等.罗库溴铵在老年人和中年人药效学比较[J].外科理论与实践,2019,24(01):60-64.DOI:10.16139/j.1007-9610.2019.01.013.
黄瑞萍,卜莹慧,角述兰,李灿兴,李梦帆,思永玉,周艺蕉,向兵兵.罗库溴铵在不同程度烧伤患者体内的药代动力学研究[J].中国药业,2023,32(22):73-77.DOI:10.3969/j.issn.1006-4931.2023.22.016.
李沂萱,李建立,容俊芳.肌松药残余肌松作用影响因素的研究进展[J].中华老年多器官疾病杂志,2018,17(10):777-779.
黄诗倩,夏海发,姚尚龙,等.全身麻醉后肌松残余的研究进展[J].临床麻醉学杂志,2020,36(12):1226-1228.
张宇,苏艾中,马丽丽,刘思洋.全麻术后肌松药物残余研究进展[J].世界最新医学信息文摘,2018,18(76):103-104+106.
Sundman E, Witt H, Olsson R, et al. The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans: pharyngeal videoradiography and simultaneous manometry after atracurium. Anesthesiology.2000;92:977-984.
李德媛.胸科术后残余肌松及术中肌松药管理的研究[D].上海交通大学,2017.
韩乐,张雨,邱嘉欣,等.全身麻醉中肌肉松弛拮抗剂应用的研究进展[J].赣南医科大学学报,2024,44(11):1176-1180.
Deyhim N,Beck A,Balk J,et al. Impact of Sugammadex Versus Neostigmine / Glycopyrrolate on Perioperative Efficiency[J]. Clini-coecon Outcomes Res,2020,12: 69-79.
韩斌,车向明,白云波.舒更葡糖的临床应用进展[J].医学综述,2021,27(02):375-379.
DOI: http://dx.doi.org/10.12345/yzlcyxzz.v8i7.30091
Refbacks
- 当前没有refback。

此作品已接受知识共享署名-非商业性使用 4.0国际许可协议的许可。





